Kwality Pharmaceuticals Ltd — Important, 04-02-2026: Company Update

Kwality Pharmaceuticals announced that two Independent Directors, Mr. Pankaj Takkar and Mr. Ravi Shanker Singh, completed their second term and ceased their directorships and committee memberships on January 31, 2026. The company reported a procedural delay in disclosing this change but clarified that it had no financial or operational impact and did not prejudice shareholders. New compositions for the Audit, Nomination & Remuneration, Stakeholders Relationship, and Corporate Social Responsibility committees are now effective, reflecting these changes. This ensures continuity in board governance.